Literature DB >> 23648195

Growth factor content in PRP and their applicability in medicine.

A Lubkowska1, B Dolegowska, G Banfi.   

Abstract

This paper reviews available reports on the advantages and possibilities of clinical use of platelet-rich plasma preparations, with particular emphasis on platelet growth factors. Platelets, an important reservoir of growth factors in the body, play an important role in many processes such as coagulation, immune response, angiogenesis and the healing of damaged tissues. Numerous proteins are contained in the alpha-granules of platelets: platelet-derived growth factor (PDGF), transforming growth factor (TGF), platelet factor interleukin (IL), platelet-derived angiogenesis factor (PDAF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), insulin-like growth factor IGF and fibronectin. The development of methods and systems for blood and cell sorting (e.g. CAPSS - compact advanced platelet sequestration system Elektromedics 500, PCCS - platelet concentrate collection system Curasan) have made it possible to obtain significant concentrations of platelets (even by 338 percent) and high concentrations of growth factors, in a form of sterile mass that can be used immediately for clinical purposes. Platelet-rich plasma (PRP; autologous platelet-rich plasma - APRP) are platelet concentrates made of autogenous blood with a high number of platelets in a small volume of plasma. The clinical efficacy of platelet concentrates depends mainly on the number of platelets and the concentration of their growth factors, which act as transmitters in most processes in tissues, particularly in healing where they are responsible for proliferation, differentiation, chemotaxis and tissue morphogenesis. They operate as part of autocrine, paracrine and endocrine mechanisms. Growth factors derived from centrifuged blood were first used in patients with chronic skin ulcers. The clinical use of PRP for a wide variety of applications has been reported mostly in oral and maxillo-facial surgery, orthopedic surgery, treatment of soft tissue diseases and injuries, treatment of burns, hard-to-heal wounds, tissue engineering and implantology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23648195

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  57 in total

1.  Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability.

Authors:  Hidemi Hattori; Masayuki Ishihara
Journal:  Exp Ther Med       Date:  2017-01-13       Impact factor: 2.447

2.  Advancing biomaterials of human origin for tissue engineering.

Authors:  Fa-Ming Chen; Xiaohua Liu
Journal:  Prog Polym Sci       Date:  2015-03-28       Impact factor: 29.190

3.  Micro- and Nanoparticles for Treating Cardiovascular Disease.

Authors:  S Suarez; A Almutairi; K L Christman
Journal:  Biomater Sci       Date:  2015-04       Impact factor: 6.843

4. 

Authors:  C Hanriat; C Barani; A Mojallal; F Braye; S Brosset
Journal:  Ann Burns Fire Disasters       Date:  2021-03-31

5.  Effect of autologous platelet-rich plasma on the chondrogenic differentiation of rabbit adipose-derived stem cells in vitro.

Authors:  Xiao-Bo Tang; Pei-Long Dong; Jian Wang; Hai-Yang Zhou; Hai-Xiang Zhang; Shan-Zheng Wang
Journal:  Exp Ther Med       Date:  2015-05-28       Impact factor: 2.447

6.  Therapeutic Potential of Platelet-Rich Plasma in Canine Medicine.

Authors:  K Sharun; K Jambagi; K Dhama; R Kumar; A M Pawde
Journal:  Arch Razi Inst       Date:  2021-10-31

7.  Harnessing biomolecules for bioinspired dental biomaterials.

Authors:  Nicholas G Fischer; Eliseu A Münchow; Candan Tamerler; Marco C Bottino; Conrado Aparicio
Journal:  J Mater Chem B       Date:  2020-08-04       Impact factor: 6.331

Review 8.  Platelets and cancer: a casual or causal relationship: revisited.

Authors:  David G Menter; Stephanie C Tucker; Scott Kopetz; Anil K Sood; John D Crissman; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

9.  The effect of lyophilized platelet rich-plasma on skin aging: a non-randomized, controlled, pilot trial.

Authors:  Letícia Queiroz da Silva; Rebeca Brito Bonani Cancela; Silmara Aparecida de Lima Montalvão; Stephany Cares Huber; Gislaine Vieira-Damiani; Renata Marchi Triglia; Joyce Maria Annichino-Bizzacchi
Journal:  Arch Dermatol Res       Date:  2021-02-07       Impact factor: 3.017

10.  Evaluation of platelet-rich plasma applied in the coronary band of healthy equine hooves.

Authors:  Sarah Raphaela Torquato Seidel; Anderson Fernando de Souza; Joice Fülber; Paulo Moreira Bogossian; Nubia Nayara Pereira Rodrigues; Raquel Yvonne Arantes Baccarin
Journal:  Can Vet J       Date:  2021-07       Impact factor: 1.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.